Most pediatric chemotherapy mistakes reach patients

The vast majority of chemotherapy errors identified in children reach patients, according to one of the first epidemiological studies of cancer drug errors in children. Published in the July 1, 2007 issue of CANCER, a peer-reviewed journal of the [i]American Cancer Society[/i], the study concluded that the antimetabolite class of chemotherapeutic agents are most likely associated with errors, and that errors in drug administration and errors in drug dosing and frequency were the most common mistakes made and consequently, the most potentially harmful.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news99285990.html">Most pediatric chemotherapy mistakes reach patients</a></p> <p>The vast majority of chemotherapy errors identified in children reach patients, according to one of the first epidemiological studies of cancer drug errors in children. Published in the July 1, 2007 issue of CANCER, a peer-reviewed journal of the [i]American Cancer Society[/i], the study concluded that the antimetabolite class of chemotherapeutic agents are most likely associated with errors, and that errors in drug administration and errors in drug dosing and frequency were the most common mistakes made and consequently, the most potentially harmful.</p>